Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-020347

EVP, CFO & CBO acquired 2,500 shares (option exercise)

  • EVP, CFO & CBO gave up 734 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-15 Exercise or conversion : show line 1 in the form +2,500 $23.85 $59,625 43,395 D
2018-03-15 Shares withheld for taxes : show line 2 in the form −734 $81.22 $59,615 42,661 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-03-15 Exercise or conversion : show line 3 in the form Stock option (right to buy) −2,500 $23.85 2022-11-05 2,500 11,768 D
Loading xslF345X03/doc4.xml…